Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL GILLIN and RADHE MOHAN.
Connection Strength
1.246
-
A procedure to determine the planar integral spot dose values of proton pencil beam spots. Med Phys. 2012 Feb; 39(2):891-900.
Score: 0.104
-
Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams. Phys Med Biol. 2010 Feb 07; 55(3):711-21.
Score: 0.090
-
Exploration of the potential of liquid scintillators for real-time 3D dosimetry of intensity modulated proton beams. Med Phys. 2009 May; 36(5):1736-43.
Score: 0.086
-
Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions. Phys Med Biol. 2008 Aug 21; 53(16):4455-70.
Score: 0.081
-
Incorporating partial shining effects in proton pencil-beam dose calculation. Phys Med Biol. 2008 Feb 07; 53(3):605-16.
Score: 0.078
-
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):620-9.
Score: 0.073
-
Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2005 Oct 01; 63(2):594-601.
Score: 0.067
-
A comparison of two methodologies for radiotherapy treatment plan optimization and QA for clinical trials. J Appl Clin Med Phys. 2021 Oct; 22(10):329-337.
Score: 0.050
-
Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer. Int J Part Ther. 2017; 4(2):26-34.
Score: 0.039
-
Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol. 2017 02; 122(2):274-280.
Score: 0.037
-
Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. Radiat Oncol. 2016 May 04; 11:66.
Score: 0.035
-
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367.
Score: 0.034
-
Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. Radiother Oncol. 2015 Mar; 114(3):367-72.
Score: 0.032
-
Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):846-53.
Score: 0.030
-
Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial. Radiat Oncol. 2014 May 06; 9:108.
Score: 0.030
-
Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation. J Thorac Oncol. 2013 Dec; 8(12):1484-91.
Score: 0.029
-
Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim. 2013; 38(4):390-4.
Score: 0.029
-
Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system. Med Phys. 2012 Mar; 39(3):1239-46.
Score: 0.026
-
Parameterization of multiple Bragg curves for scanning proton beams using simultaneous fitting of multiple curves. Phys Med Biol. 2011 Dec 21; 56(24):7725-35.
Score: 0.026
-
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011 Oct 15; 117(20):4707-13.
Score: 0.024
-
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1350-7.
Score: 0.024
-
An MCNPX Monte Carlo model of a discrete spot scanning proton beam therapy nozzle. Med Phys. 2010 Sep; 37(9):4960-70.
Score: 0.024
-
Experimental characterization of the low-dose envelope of spot scanning proton beams. Phys Med Biol. 2010 Jun 21; 55(12):3467-78.
Score: 0.023
-
The M. D. Anderson proton therapy system. Med Phys. 2009 Sep; 36(9):4068-83.
Score: 0.022
-
Liquid scintillator for 2D dosimetry for high-energy photon beams. Med Phys. 2009 May; 36(5):1478-85.
Score: 0.021
-
Proton radiotherapy for liver tumors: dosimetric advantages over photon plans. Med Dosim. 2008; 33(4):259-67.
Score: 0.020
-
Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys. 2007 Dec; 34(12):4591-3.
Score: 0.019
-
Reduced neutron production through use of a flattening-filter-free accelerator. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1260-4.
Score: 0.019
-
Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):968-70.
Score: 0.019
-
Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):630-8.
Score: 0.018
-
Monte Carlo study of photon fields from a flattening filter-free clinical accelerator. Med Phys. 2006 Apr; 33(4):820-7.
Score: 0.017
-
Dosimetric properties of photon beams from a flattening filter free clinical accelerator. Phys Med Biol. 2006 Apr 07; 51(7):1907-17.
Score: 0.017